{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:05:35Z","timestamp":1790240735195,"version":"4.1.0"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s10555-013-9484-y","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T07:40:36Z","timestamp":1389080436000},"page":"527-543","source":"Crossref","is-referenced-by-count":103,"title":["Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases"],"prefix":"10.1007","volume":"33","author":[{"given":"Aimalie L.","family":"Hardaway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie K.","family":"Herroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erandi","family":"Rajagurubandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Podgorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"issue":"2","key":"9484_CR1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2011.06.032","volume":"50","author":"B Lecka-Czernik","year":"2011","unstructured":"Lecka-Czernik, B. (2011). Marrow fat metabolism is linked to the systemic energy metabolism. Bone, 50(2), 534\u2013539.","journal-title":"Bone"},{"key":"9484_CR2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., Zhang, Z., Kim, J. K., Mauvais-Jarvis, F., Ducy, P., & Karsenty, G. (2007). Endocrine regulation of energy metabolism by the skeleton. Cell, 130, 456\u2013469.","journal-title":"Cell"},{"key":"9484_CR3","first-page":"411","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011). Cancer to bone: a fatal attraction. Nature Reviews, 11, 411\u2013425.","journal-title":"Nature Reviews"},{"key":"9484_CR4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman, G. D. (2004). Mechanisms of bone metastasis. New England Journal of Medicine, 350, 1655\u20131664.","journal-title":"New England Journal of Medicine"},{"key":"9484_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman, R. E. (2001). Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treatment Reviews, 27, 165\u2013176.","journal-title":"Cancer Treatment Reviews"},{"key":"9484_CR6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1158\/1055-9965.EPI-06-0777","volume":"16","author":"P Tuohimaa","year":"2007","unstructured":"Tuohimaa, P., Tenkanen, L., Syvala, H., Lumme, S., Hakulinen, T., Dillner, J., & Hakama, M. (2007). Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer. Cancer Epidemiology, Biomarkers and Prevention, 16, 302\u2013307.","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"9484_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.mou.0000165550.94663.fb","volume":"15","author":"CL Amling","year":"2005","unstructured":"Amling, C. L. (2005). Relationship between obesity and prostate cancer. Current Opinion in Urology, 15, 167\u2013171.","journal-title":"Current Opinion in Urology"},{"key":"9484_CR8","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","volume":"15","author":"Z Gong","year":"2006","unstructured":"Gong, Z., Neuhouser, M. L., Goodman, P. J., Albanes, D., Chi, C., Hsing, A. W., Lippman, S. M., Platz, E. A., Pollak, M. N., Thompson, I. M., & Kristal, A. R. (2006). Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiology, Biomarkers and Prevention, 15, 1977\u20131983.","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"9484_CR9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jnci\/93.10.783","volume":"93","author":"AW Hsing","year":"2001","unstructured":"Hsing, A. W., Chua, S., Jr., Gao, Y. T., Gentzschein, E., Chang, L., Deng, J., & Stanczyk, F. Z. (2001). Prostate cancer risk and serum levels of insulin and leptin: a population-based study. Journal of the National Cancer Institute, 93, 783\u2013789.","journal-title":"Journal of the National Cancer Institute"},{"key":"9484_CR10","doi-asserted-by":"crossref","first-page":"s843","DOI":"10.1093\/ajcn\/86.3.843S","volume":"86","author":"AW Hsing","year":"2007","unstructured":"Hsing, A. W., Sakoda, L. C., & Chua, S., Jr. (2007). Obesity, metabolic syndrome, and prostate cancer. The American Journal of Clinical Nutrition., 86, s843\u2013857.","journal-title":"The American Journal of Clinical Nutrition."},{"key":"9484_CR11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.urology.2003.09.060","volume":"63","author":"JS Hubbard","year":"2004","unstructured":"Hubbard, J. S., Rohrmann, S., Landis, P. K., Metter, E. J., Muller, D. C., Andres, R., Carter, H. B., & Platz, E. A. (2004). Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology, 63, 253\u2013258.","journal-title":"Urology"},{"key":"9484_CR12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.bjc.6602983","volume":"94","author":"N Kurahashi","year":"2006","unstructured":"Kurahashi, N., Iwasaki, M., Sasazuki, S., Otani, T., Inoue, M., & Tsugane, S. (2006). Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men. British Journal of Cancer, 94, 740\u2013742.","journal-title":"British Journal of Cancer"},{"key":"9484_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1158\/1055-9965.EPI-06-0754","volume":"16","author":"C Rodriguez","year":"2007","unstructured":"Rodriguez, C., Freedland, S. J., Deka, A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2007). Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiology, Biomarkers and Prevention, 16, 63\u201369.","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"9484_CR14","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/cncr.26392","volume":"118","author":"E Scosyrev","year":"2012","unstructured":"Scosyrev, E., Messing, E. M., Mohile, S., Golijanin, D., & Wu, G. (2012). Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer, 118, 3062\u20133070.","journal-title":"Cancer"},{"key":"9484_CR15","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1002\/cncr.27503","volume":"118","author":"E Scosyrev","year":"2012","unstructured":"Scosyrev, E., Wu, G., Mohile, S., & Messing, E. M. (2012). Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : Analysis of trends over time. Cancer, 118, 5768\u20135776.","journal-title":"Cancer"},{"key":"9484_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1047-2797(00)00057-0","volume":"10","author":"SD Putnam","year":"2000","unstructured":"Putnam, S. D., Cerhan, J. R., Parker, A. S., Bianchi, G. D., Wallace, R. B., Cantor, K. P., & Lynch, C. F. (2000). Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Annals of Epidemiology, 10, 361\u2013369.","journal-title":"Annals of Epidemiology"},{"key":"9484_CR17","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/sj.bjc.6601859","volume":"90","author":"L Dal Maso","year":"2004","unstructured":"Dal Maso, L., Zucchetto, A., La Vecchia, C., Montella, M., Conti, E., Canzonieri, V., Talamini, R., Tavani, A., Negri, E., Garbeglio, A., & Franceschi, S. (2004). Prostate cancer and body size at different ages: an Italian multicentre case\u2013control study. British Journal of Cancer, 90, 2176\u20132180.","journal-title":"British Journal of Cancer"},{"key":"9484_CR18","first-page":"1417","volume":"12","author":"RJ MacInnis","year":"2003","unstructured":"MacInnis, R. J., English, D. R., Gertig, D. M., Hopper, J. L., & Giles, G. G. (2003). Body size and composition and prostate cancer risk. Cancer Epidemiology, Biomarkers and Prevention, 12, 1417\u20131421.","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"9484_CR19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/pcan.2009.11","volume":"12","author":"SJ Freedland","year":"2009","unstructured":"Freedland, S. J., Banez, L. L., Sun, L. L., Fitzsimons, N. J., & Moul, J. W. (2009). Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer and Prostatic Diseases, 12, 259\u2013263.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"9484_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.2004.03.132","volume":"22","author":"CL Amling","year":"2004","unstructured":"Amling, C. L., Riffenburgh, R. H., Sun, L., Moul, J. W., Lance, R. S., Kusuda, L., Sexton, W. J., Soderdahl, D. W., Donahue, T. F., Foley, J. P., Chung, A. K., & McLeod, D. G. (2004). Pathologic variables and recurrence ates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. Journal of Clinical Oncology, 22, 439\u2013445.","journal-title":"Journal of Clinical Oncology"},{"key":"9484_CR21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.urology.2005.05.040","volume":"66","author":"WW Bassett","year":"2005","unstructured":"Bassett, W. W., Cooperberg, M. R., Sadetsky, N., Silva, S., DuChane, J., Pasta, D. J., Chan, J. M., Anast, J. W., Carroll, P. R., & Kane, C. J. (2005). Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology, 66, 1060\u20131065.","journal-title":"Urology"},{"key":"9484_CR22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2004.04.181","volume":"22","author":"SJ Freedland","year":"2004","unstructured":"Freedland, S. J., Aronson, W. J., Kane, C. J., Presti, J. C., Jr., Amling, C. L., Elashoff, D., & Terris, M. K. (2004). Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. Journal of Clinical Oncology, 22, 446\u2013453.","journal-title":"Journal of Clinical Oncology"},{"key":"9484_CR23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.ju.0000169459.78982.d7","volume":"174","author":"SJ Freedland","year":"2005","unstructured":"Freedland, S. J., Grubb, K. A., Yiu, S. K., Humphreys, E. B., Nielsen, M. E., Mangold, L. A., Isaacs, W. B., & Partin, A. W. (2005). Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. The Journal of Urology, 174, 919\u2013922.","journal-title":"The Journal of Urology"},{"key":"9484_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1464-410X.2007.06897.x","volume":"100","author":"D Palma","year":"2007","unstructured":"Palma, D., Pickles, T., & Tyldesley, S. (2007). Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU International, 100, 315\u2013319.","journal-title":"BJU International"},{"key":"9484_CR25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/cncr.22873","volume":"110","author":"SP Stroup","year":"2007","unstructured":"Stroup, S. P., Cullen, J., Auge, B. K., L\u2019Esperance, J. O., & Kang, S. K. (2007). Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Cancer, 110, 1003\u20131009.","journal-title":"Cancer"},{"key":"9484_CR26","first-page":"345","volume":"10","author":"C Rodriguez","year":"2001","unstructured":"Rodriguez, C., Patel, A. V., Calle, E. E., Jacobs, E. J., Chao, A., & Thun, M. J. (2001). Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiology, Biomarkers and Prevention, 10, 345\u2013353.","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"9484_CR27","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine, 348, 1625\u20131638.","journal-title":"New England Journal of Medicine"},{"key":"9484_CR28","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/cncr.22534","volume":"109","author":"Z Gong","year":"2007","unstructured":"Gong, Z., Agalliu, I., Lin, D. W., Stanford, J. L., & Kristal, A. R. (2007). Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer, 109, 1192\u20131202.","journal-title":"Cancer"},{"key":"9484_CR29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1464-410X.2011.10754.x","volume":"110","author":"CJ Keto","year":"2012","unstructured":"Keto, C. J., Aronson, W. J., Terris, M. K., Presti, J. C., Kane, C. J., Amling, C. L., & Freedland, S. J. (2012). Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database. BJU International, 110, 492\u2013498.","journal-title":"BJU International"},{"key":"9484_CR30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/10715762.2013.772604","volume":"47","author":"AB Crujeiras","year":"2013","unstructured":"Crujeiras, A. B., Diaz-Lagares, A., Carreira, M. C., Amil, M., & Casanueva, F. F. (2013). Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radical Research, 47, 243\u2013256.","journal-title":"Free Radical Research"},{"key":"9484_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/pcan.2011.64","volume":"15","author":"G Gueron","year":"2012","unstructured":"Gueron, G., De Siervi, A., & Vazquez, E. (2012). Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior. Prostate Cancer and Prostatic Diseases, 15, 213\u2013221.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"9484_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1020110718701","volume":"21","author":"WG Nelson","year":"2002","unstructured":"Nelson, W. G., DeWeese, T. L., & DeMarzo, A. M. (2002). The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Reviews, 21, 3\u201316.","journal-title":"Cancer Metastasis Reviews"},{"key":"9484_CR33","first-page":"1765","volume":"4","author":"M Imbriaco","year":"1998","unstructured":"Imbriaco, M., Larson, S. M., Yeung, H. W., Mawlawi, O. R., Erdi, Y., Venkatraman, E. S., & Scher, H. I. (1998). A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index. Clinical Cancer Research, 4, 1765\u20131772.","journal-title":"Clinical Cancer Research"},{"key":"9484_CR34","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/en.2004-1211","volume":"146","author":"A Schneider","year":"2005","unstructured":"Schneider, A., Kalikin, L. M., Mattos, A. C., Keller, E. T., Allen, M. J., Pienta, K. J., & McCauley, L. K. (2005). Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology, 146, 1727\u20131736.","journal-title":"Endocrinology"},{"key":"9484_CR35","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","volume":"12","author":"TA Guise","year":"2006","unstructured":"Guise, T. A., Mohammad, K. S., Clines, G., Stebbins, E. G., Wong, D. H., Higgins, L. S., Vessella, R., Corey, E., Padalecki, S., Suva, L., & Chirgwin, J. M. (2006). Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clinical Cancer Research, 12, 6213s\u20136216s.","journal-title":"Clinical Cancer Research"},{"key":"9484_CR36","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1158\/0008-5472.CAN-11-2928","volume":"72","author":"SI Park","year":"2012","unstructured":"Park, S. I., Liao, J., Berry, J. E., Li, X., Koh, A. J., Michalski, M. E., Eber, M. R., Soki, F. N., Sadler, D., Sud, S., Tisdelle, S., Daignault, S. D., Nemeth, J. A., Snyder, L. A., Wronski, T. J., Pienta, K. J., & McCauley, L. K. (2012). Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Cancer Research, 72, 2522\u20132532.","journal-title":"Cancer Research"},{"key":"9484_CR37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.bjc.6603030","volume":"94","author":"MD Brown","year":"2006","unstructured":"Brown, M. D., Hart, C. A., Gazi, E., Bagley, S., & Clarke, N. W. (2006). Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAS. British Journal of Cancer, 94, 842\u2013853.","journal-title":"British Journal of Cancer"},{"key":"9484_CR38","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1194\/jlr.M700131-JLR200","volume":"48","author":"E Gazi","year":"2007","unstructured":"Gazi, E., Gardner, P., Lockyer, N. P., Hart, C. A., Brown, M. D., & Clarke, N. W. (2007). Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. Journal of Lipid Research, 48, 1846\u20131856.","journal-title":"Journal of Lipid Research"},{"key":"9484_CR39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/ENDO:23:2-3:183","volume":"23","author":"JM Gimble","year":"2004","unstructured":"Gimble, J. M., & Nuttall, M. E. (2004). Bone and fat: old questions, new insights. Endocrine, 23, 183\u2013188.","journal-title":"Endocrine"},{"key":"9484_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncprheum0070","volume":"2","author":"C Rosen","year":"2006","unstructured":"Rosen, C., & Bouxsein, M. (2006). Mechanisms of disease: is osteoporosis the obesity of bone? Nature Clinical Practice Rheumatology, 2, 35\u201343.","journal-title":"Nature Clinical Practice Rheumatology"},{"issue":"Pt 2","key":"9484_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1242\/jcs.102.2.341","volume":"102","author":"JN Beresford","year":"1992","unstructured":"Beresford, J. N., Bennett, J. H., Devlin, C., Leboy, P. S., & Owen, M. E. (1992). Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. Journal of Cell Science, 102(Pt 2), 341\u2013351.","journal-title":"Journal of Cell Science"},{"key":"9484_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1242\/jcs.1988.Supplement_10.5","volume":"10","author":"M Owen","year":"1988","unstructured":"Owen, M. (1988). Marrow stromal stem cells. Journal of Cell Science, 10, 63\u201376 (Supplement).","journal-title":"Journal of Cell Science"},{"key":"9484_CR43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2796.2012.02564.x","volume":"272","author":"M Kawai","year":"2012","unstructured":"Kawai, M., de Paula, F., & Rosen, C. (2012). New insights into osteoporosis: the bone-fat connection. Journal of Internal Medicine, 272, 317\u2013329.","journal-title":"Journal of Internal Medicine"},{"key":"9484_CR44","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.4161\/cc.9.18.13046","volume":"9","author":"B Lecka-Czernik","year":"2010","unstructured":"Lecka-Czernik, B., Rosen, C. J., & Kawai, M. (2010). Skeletal aging and the adipocyte program: new insights from an \u201cold\u201d molecule. Cell Cycle, 9, 3648\u20133654.","journal-title":"Cell Cycle"},{"key":"9484_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i2.20","volume":"19","author":"CJ Rosen","year":"2009","unstructured":"Rosen, C. J., Ackert-Bicknell, C., Rodriguez, J. P., & Pino, A. M. (2009). Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Critical Reviews in Eukaryotic Gene Expression, 19, 109\u2013124.","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"key":"9484_CR46","first-page":"581","volume":"2","author":"RL Jilka","year":"2002","unstructured":"Jilka, R. L. (2002). Osteoblast progenitor fate and age-related bone loss. Journal of Musculoskeletal & Neuronal Interactions, 2, 581\u2013583.","journal-title":"Journal of Musculoskeletal & Neuronal Interactions"},{"key":"9484_CR47","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1194\/jlr.M800626","volume":"51","author":"S Oh","year":"2010","unstructured":"Oh, S., Sul, O., Kim, Y., Kim, H., Yu, R., Suh, J., & Choi, H. (2010). Saturated fatty acids enhance osteoclast survival. Journal of Lipid Research, 51, 892\u2013899.","journal-title":"Journal of Lipid Research"},{"key":"9484_CR48","doi-asserted-by":"crossref","first-page":"e13704","DOI":"10.1371\/journal.pone.0013704","volume":"5","author":"J Chen","year":"2010","unstructured":"Chen, J., Lazarenko, O., Wu, X., Tong, Y., Blackburn, M., Shankar, K., Badger, T., & Ronis, M. (2010). Obesity reduces bone density associated with activation of PPAR\u03b3 and suppression of Wnt\/\u03b2-catenin in rapidly growing male rats. PLoS ONE, 5, e13704.","journal-title":"PLoS ONE"},{"key":"9484_CR49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1474-9728.2004.00127.x","volume":"3","author":"EJ Moerman","year":"2004","unstructured":"Moerman, E. J., Teng, K., Lipschitz, D. A., & Lecka-Czernik, B. (2004). Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma\/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta\/BMP signaling pathways. Aging Cell, 3, 379\u2013389.","journal-title":"Aging Cell"},{"key":"9484_CR50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1138\/20070257","volume":"4","author":"G Duque","year":"2007","unstructured":"Duque, G. (2007). As a matter of fat: new perspectives on the understanding of age-related bone loss. BoneKEy-Osteovision., 4, 129\u2013140.","journal-title":"BoneKEy-Osteovision."},{"key":"9484_CR51","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm1672","volume":"13","author":"Y Wan","year":"2007","unstructured":"Wan, Y., Chong, L. W., & Evans, R. M. (2007). PPAR-gamma regulates osteoclastogenesis in mice. Nature Medicine, 13, 1496\u20131503.","journal-title":"Nature Medicine"},{"key":"9484_CR52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11914-010-0016-1","volume":"8","author":"B Lecka-Czernik","year":"2010","unstructured":"Lecka-Czernik, B. (2010). PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism. Current Osteoporosis Reports, 8, 84\u201390.","journal-title":"Current Osteoporosis Reports"},{"key":"9484_CR53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1749-799X-6-30","volume":"6","author":"J Cao","year":"2011","unstructured":"Cao, J. (2011). Effects of obesity on bone metabolism. Journal of Orthopaedic Surgery and Research, 6, 30. doi: 10.1186\/1749-799X-6-30 .","journal-title":"Journal of Orthopaedic Surgery and Research"},{"key":"9484_CR54","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/oby.2005.228","volume":"13","author":"DT Villareal","year":"2005","unstructured":"Villareal, D. T., Apovian, C. M., Kushner, R. F., Klein, S., American Society for Nutrition, & Naaso TOS. (2005). Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obesity Research, 13, 1849\u20131863.","journal-title":"Obesity Research"},{"key":"9484_CR55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2007.12.224","volume":"42","author":"LF Bonewald","year":"2008","unstructured":"Bonewald, L. F., & Johnson, M. L. (2008). Osteocytes, mechanosensing and Wnt signaling. Bone, 42, 606\u2013615.","journal-title":"Bone"},{"key":"9484_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1486","volume":"27","author":"CM Nielson","year":"2012","unstructured":"Nielson, C. M., Srikanth, P., & Orwoll, E. S. (2012). Obesity and fracture in men and women: an epidemiologic perspective. Journal of Bone and Mineral Research, 27, 1\u201310.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9484_CR57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ajcn\/83.1.146","volume":"83","author":"YH Hsu","year":"2006","unstructured":"Hsu, Y. H., Venners, S. A., Terwedow, H. A., Feng, Y., Niu, T., Li, Z., Laird, N., Brain, J. D., Cummings, S. R., Bouxsein, M. L., Rosen, C. J., & Xu, X. (2006). Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. The American Journal of Clinical Nutrition, 83, 146\u2013154.","journal-title":"The American Journal of Clinical Nutrition"},{"key":"9484_CR58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/j.1550-8528.1998.tb00309.x","volume":"6","author":"W Owusu","year":"1998","unstructured":"Owusu, W., Willett, W., Ascherio, A., Spiegelman, D., Rimm, E., Feskanich, D., & Colditz, G. (1998). Body anthropometry and the risk of hip and wrist fractures in men: results from a prospective study. Obesity Research, 6, 12\u201319.","journal-title":"Obesity Research"},{"key":"9484_CR59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1522-2586(200102)13:2<263::AID-JMRI1038>3.0.CO;2-M","volume":"13","author":"H Kugel","year":"2001","unstructured":"Kugel, H., Jung, C., Schulte, O., & Heindel, W. (2001). Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow. Journal of Magnetic Resonance Imaging, 13, 263\u2013268.","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"9484_CR60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1011513223894","volume":"2","author":"J Justesen","year":"2001","unstructured":"Justesen, J., Stenderup, K., Ebbesen, E. N., Mosekilde, L., Steiniche, T., & Kassem, M. (2001). Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology, 2, 165\u2013171.","journal-title":"Biogerontology"},{"key":"9484_CR61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.2009.05252.x","volume":"1192","author":"J Cao","year":"2010","unstructured":"Cao, J., Sun, L., & Gao, H. (2010). Diet-induced obesity alters bone remodeling leading to decreased femoral trabecular bone mass in mice. Annals of the New York Academy of Sciences, 1192, 292\u2013297.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"9484_CR62","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bone.2009.02.017","volume":"44","author":"JJ Cao","year":"2009","unstructured":"Cao, J. J., Gregoire, B. R., & Gao, H. (2009). High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone, 44, 1097\u20131104.","journal-title":"Bone"},{"key":"9484_CR63","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jnutbio.2009.10.002","volume":"21","author":"G Halade","year":"2010","unstructured":"Halade, G., Rahman, M., Williams, P., & Fernandes, G. (2010). High fat diet-induced animal model of age-associated obesity and osteoporosis. Journal of Nutritional Biochemistry, 21, 1162\u20131169.","journal-title":"Journal of Nutritional Biochemistry"},{"key":"9484_CR64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exger.2010.09.014","volume":"46","author":"G Halade","year":"2011","unstructured":"Halade, G., El Jamali, A., Williams, P., Fajardo, R., & Fernandes, G. (2011). Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Experimental Gerontology, 46, 43\u201352.","journal-title":"Experimental Gerontology"},{"key":"9484_CR65","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3945\/jn.108.100032","volume":"139","author":"T Kyung","year":"2009","unstructured":"Kyung, T., Lee, J., Phan, T., Yu, R., & Choi, H. (2009). Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice. Journal of Nutrition, 139, 502\u2013506.","journal-title":"Journal of Nutrition"},{"key":"9484_CR66","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bone.2011.06.016","volume":"50","author":"A Krings","year":"2012","unstructured":"Krings, A., Rahman, S., Huang, S., Lu, Y., Czernik, P. J., & Lecka-Czernik, B. (2012). Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone, 50, 546\u2013552.","journal-title":"Bone"},{"key":"9484_CR67","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jc.2012-3634","volume":"98","author":"PK Fazeli","year":"2013","unstructured":"Fazeli, P. K., Horowitz, M. C., MacDougald, O. A., Scheller, E. L., Rodeheffer, M. S., Rosen, C. J., & Klibanski, A. (2013). Marrow fat and bone\u2013new perspectives. The Journal of Clinical Endocrinology and Metabolism, 98, 935\u2013945.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"9484_CR68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcb.20777","volume":"98","author":"JM Gimble","year":"2006","unstructured":"Gimble, J. M., Zvonic, S., Floyd, Z. E., Kassem, M., & Nuttall, M. E. (2006). Playing with bone and fat. Journal of Cellular Biochemistry, 98, 251\u2013266.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9484_CR69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7","volume":"74","author":"B Lecka-Czernik","year":"1999","unstructured":"Lecka-Czernik, B., Gubrij, I., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., & Jilka, R. L. (1999). Inhibition of Osf2\/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. Journal of Cellular Biochemistry, 74, 357\u2013371.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9484_CR70","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jcb.21994","volume":"106","author":"KR Shockley","year":"2009","unstructured":"Shockley, K. R., Lazarenko, O. P., Czernik, P. J., Rosen, C. J., Churchill, G. A., & Lecka-Czernik, B. (2009). PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. Journal of Cellular Biochemistry, 106, 232\u2013246.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9484_CR71","first-page":"304","volume":"2","author":"JM Gimble","year":"1990","unstructured":"Gimble, J. M. (1990). The function of adipocytes in the bone marrow stroma. The New Biologist, 2, 304\u2013312.","journal-title":"The New Biologist"},{"key":"9484_CR72","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S0004-27302010000200010","volume":"54","author":"FJ Paula","year":"2010","unstructured":"Paula, F. J., & Rosen, C. J. (2010). Obesity, diabetes mellitus and last but not least, osteoporosis. Arquivos Brasileiros de Endocrinologia e Metabologia, 54, 150\u2013157.","journal-title":"Arquivos Brasileiros de Endocrinologia e Metabologia"},{"issue":"3\u20134","key":"9484_CR73","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10555-012-9372-x","volume":"31","author":"GD Roodman","year":"2012","unstructured":"Roodman, G. D. (2012). Genes associate with abnormal bone cell activity in bone metastasis. Cancer Metastasis Review, 31(3\u20134), 569\u201378.","journal-title":"Cancer Metastasis Review"},{"key":"9484_CR74","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1073\/pnas.1205129109","volume":"109","author":"MD Trottier","year":"2012","unstructured":"Trottier, M. D., Naaz, A., Li, Y., & Fraker, P. J. (2012). Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice. Proceedings of the National Academy of Sciences of the United States of America, 109, 7622\u20137629.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9484_CR75","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.ijo.0801825","volume":"25","author":"FM Dielen van","year":"2001","unstructured":"van Dielen, F. M., van\u2019t Veer, C., Schols, A. M., Soeters, P. B., Buurman, W. A., & Greve, J. W. (2001). Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. International Journal of Obesity and Related Metabolic Disorders, 25, 1759\u20131766.","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"9484_CR76","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/jbmr.361","volume":"26","author":"KE Barbour","year":"2011","unstructured":"Barbour, K. E., Zmuda, J. M., Boudreau, R., Strotmeyer, E. S., Horwitz, M. J., Evans, R. W., Kanaya, A. M., Harris, T. B., Bauer, D. C., & Cauley, J. A. (2011). Adipokines and the risk of fracture in older adults. Journal of Bone and Mineral Research, 26, 1568\u20131576.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9484_CR77","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.biochi.2012.04.015","volume":"94","author":"KJ Motyl","year":"2012","unstructured":"Motyl, K. J., & Rosen, C. J. (2012). Understanding leptin-dependent regulation of skeletal homeostasis. Biochimie, 94, 2089\u20132096.","journal-title":"Biochimie"},{"key":"9484_CR78","author":"H Sadie-Van Gijsen","year":"2012","unstructured":"Sadie-Van Gijsen, H., Crowther, N. J., Hough, F. S., & Ferris, W. F. (2012). The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity. Cellular and Molecular Life Sciences. doi: 10.1007\/s00018-012-1211-2 .","journal-title":"Cellular and Molecular Life Sciences"},{"key":"9484_CR79","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jcb.10156","volume":"85","author":"JO Gordeladze","year":"2002","unstructured":"Gordeladze, J. O., Drevon, C. A., Syversen, U., & Reseland, J. E. (2002). Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. Journal of Cellular Biochemistry, 85, 825\u2013836.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9484_CR80","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/stem.432","volume":"28","author":"EL Scheller","year":"2010","unstructured":"Scheller, E. L., Song, J., Dishowitz, M. I., Soki, F. N., Hankenson, K. D., & Krebsbach, P. H. (2010). Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells (Dayton, Ohio), 28, 1071\u20131080.","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"9484_CR81","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/endo.140.4.6637","volume":"140","author":"T Thomas","year":"1999","unstructured":"Thomas, T., Gori, F., Khosla, S., Jensen, M. D., Burguera, B., & Riggs, B. L. (1999). Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology, 140, 1630\u20131638.","journal-title":"Endocrinology"},{"key":"9484_CR82","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1359\/JBMR.040712","volume":"19","author":"MW Hamrick","year":"2004","unstructured":"Hamrick, M. W. (2004). Leptin, bone mass, and the thrifty phenotype. Journal of Bone and Mineral Research, 19, 1607\u20131611.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9484_CR83","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1359\/JBMR.050103","volume":"20","author":"MW Hamrick","year":"2005","unstructured":"Hamrick, M. W., Della-Fera, M. A., Choi, Y. H., Pennington, C., Hartzell, D., & Baile, C. A. (2005). Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob\/ob mice. Journal of Bone and Mineral Research, 20, 994\u20131001.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9484_CR84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","volume":"13","author":"AH Berg","year":"2002","unstructured":"Berg, A. H., Combs, T. P., & Scherer, P. E. (2002). ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism, 13, 84\u201389.","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"9484_CR85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2010.06.027","volume":"503","author":"IR Reid","year":"2010","unstructured":"Reid, I. R. (2010). Fat and bone. Archives of Biochemistry and Biophysics, 503, 20\u201327.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"9484_CR86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jcb.20890","volume":"99","author":"Y Shinoda","year":"2006","unstructured":"Shinoda, Y., Yamaguchi, M., Ogata, N., Akune, T., Kubota, N., Yamauchi, T., Terauchi, Y., Kadowaki, T., Takeuchi, Y., Fukumoto, S., Ikeda, T., Hoshi, K., Chung, U., Nakamura, K., & Kawaguchi, H. (2006). Regulation of bone formation by adiponectin through autocrine\/paracrine and endocrine pathways. Journal of Cellular Biochemistry, 99, 196\u2013208.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9484_CR87","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbrc.2004.08.145","volume":"323","author":"AM Wolf","year":"2004","unstructured":"Wolf, A. M., Wolf, D., Rumpold, H., Enrich, B., & Tilg, H. (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochemical and Biophysical Research Communications, 323, 630\u2013635.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9484_CR88","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.2174\/092986712803833146","volume":"19","author":"I Kanazawa","year":"2012","unstructured":"Kanazawa, I. (2012). Adiponectin in metabolic bone disease. Current Medicinal Chemistry, 19, 5481\u20135492.","journal-title":"Current Medicinal Chemistry"},{"key":"9484_CR89","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","volume":"331","author":"K Oshima","year":"2005","unstructured":"Oshima, K., Nampei, A., Matsuda, M., Iwaki, M., Fukuhara, A., Hashimoto, J., Yoshikawa, H., & Shimomura, I. (2005). Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochemical and Biophysical Research Communications, 331, 520\u2013526.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9484_CR90","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/en.2008-1639","volume":"150","author":"GA Williams","year":"2009","unstructured":"Williams, G. A., Wang, Y., Callon, K. E., Watson, M., Lin, J. M., Lam, J. B., Costa, J. L., Orpe, A., Broom, N., Naot, D., Reid, I. R., & Cornish, J. (2009). In vitro and in vivo effects of adiponectin on bone. Endocrinology, 150, 3603\u20133610.","journal-title":"Endocrinology"},{"key":"9484_CR91","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1017\/S0029665112000092","volume":"71","author":"FP Heredia de","year":"2012","unstructured":"de Heredia, F. P., Gomez-Martinez, S., & Marcos, A. (2012). Obesity, inflammation and the immune system. The Proceedings of the Nutrition Society, 71, 332\u2013338.","journal-title":"The Proceedings of the Nutrition Society"},{"key":"9484_CR92","author":"AL Harte","year":"2013","unstructured":"Harte, A. L., Tripathi, G., Piya, M. K., Barber, T. M., Clapham, J. C., Al-Daghri, N., Al-Disi, D., Kumsaiyai, W., Saravanan, P., Fowler, A. E., Oh, J. P., Kumar, S., & McTernan, P. G. (2013). NFkappaB as a potent regulator of inflammation in human adipose tissue, influenced by depot, adiposity, T2DM status, and TNFalpha. Obesity. doi: 10.1002\/oby.20336 (Silver Spring, MD).","journal-title":"Obesity"},{"key":"9484_CR93","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cmet.2013.05.008","volume":"17","author":"D Mathis","year":"2013","unstructured":"Mathis, D. (2013). Immunological goings-on in visceral adipose tissue. Cell Metabolism, 17, 851\u2013859.","journal-title":"Cell Metabolism"},{"key":"9484_CR94","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2141.2004.05198.x","volume":"127","author":"J Corre","year":"2004","unstructured":"Corre, J., Planat-Benard, V., Corberand, J. X., Penicaud, L., Casteilla, L., & Laharrague, P. (2004). Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34 cells. British Journal of Haematology, 127, 344\u2013347.","journal-title":"British Journal of Haematology"},{"key":"9484_CR95","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinbiochem.2012.03.006","volume":"45","author":"JM Gimble","year":"2012","unstructured":"Gimble, J. M., & Nuttall, M. E. (2012). The relationship between adipose tissue and bone metabolism. Clinical Biochemistry, 45, 874\u2013879.","journal-title":"Clinical Biochemistry"},{"key":"9484_CR96","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","volume":"460","author":"O Naveiras","year":"2009","unstructured":"Naveiras, O., Nardi, V., Wenzel, P. L., Hauschka, P. V., Fahey, F., & Daley, G. Q. (2009). Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature, 460, 259\u2013263.","journal-title":"Nature"},{"key":"9484_CR97","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.immuni.2010.08.017","volume":"33","author":"Y Omatsu","year":"2010","unstructured":"Omatsu, Y., Sugiyama, T., Kohara, H., Kondoh, G., Fujii, N., Kohno, K., & Nagasawa, T. (2010). The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity, 33, 387\u2013399.","journal-title":"Immunity"},{"key":"9484_CR98","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1634\/stemcells.2008-0068","volume":"26","author":"Z Belaid-Choucair","year":"2008","unstructured":"Belaid-Choucair, Z., Lepelletier, Y., Poncin, G., Thiry, A., Humblet, C., Maachi, M., Beaulieu, A., Schneider, E., Briquet, A., Mineur, P., Lambert, C., Mendes-Da-Cruz, D., Ahui, M. L., Asnafi, V., Dy, M., Boniver, J., Nusgens, B. V., Hermine, O., & Defresne, M. P. (2008). Human bone marrow adipocytes block granulopoiesis through neuropilin-1-induced granulocyte colony-stimulating factor inhibition. Stem Cells (Dayton, Ohio), 26, 1556\u20131564.","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"9484_CR99","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jcp.21334","volume":"215","author":"K Miharada","year":"2008","unstructured":"Miharada, K., Hiroyama, T., Sudo, K., Danjo, I., Nagasawa, T., & Nakamura, Y. (2008). Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte\/macrophage lineage cells. Journal of Cellular Physiology, 215, 526\u2013537.","journal-title":"Journal of Cellular Physiology"},{"key":"9484_CR100","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.4049\/jimmunol.178.6.3511","volume":"178","author":"L DiMascio","year":"2007","unstructured":"DiMascio, L., Voermans, C., Uqoezwa, M., Duncan, A., Lu, D., Wu, J., Sankar, U., & Reya, T. (2007). Identification of adiponectin as a novel hemopoietic stem cell growth factor. The Journal of Immunology, 178, 3511\u20133520.","journal-title":"The Journal of Immunology"},{"key":"9484_CR101","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259, 87\u201391.","journal-title":"Science"},{"key":"9484_CR102","doi-asserted-by":"crossref","first-page":"20012","DOI":"10.1073\/pnas.1116110108","volume":"108","author":"WW Pang","year":"2011","unstructured":"Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., Rossi, D. J., Schrier, S. L., & Weissman, I. L. (2011). Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proceedings of the National Academy of Sciences of the United States of America, 108, 20012\u201320017.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9484_CR103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0047-6374(00)00137-8","volume":"117","author":"T Ogawa","year":"2000","unstructured":"Ogawa, T., Kitagawa, M., & Hirokawa, K. (2000). Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mechanisms of Ageing and Development, 117, 57\u201368.","journal-title":"Mechanisms of Ageing and Development"},{"key":"9484_CR104","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00262-003-0443-2","volume":"53","author":"P Serafini","year":"2004","unstructured":"Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., & Bronte, V. (2004). Derangement of immune responses by myeloid suppressor cells. Cancer Immunology, Immunotherapy, 53, 64\u201372.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"9484_CR105","doi-asserted-by":"crossref","first-page":"34342","DOI":"10.1074\/jbc.M109.042671","volume":"284","author":"H Roca","year":"2009","unstructured":"Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Ying, C., & Pienta, K. J. (2009). CCL2 and interleukin-6 promote survival of human CD11b\u2009+\u2009peripheral blood mononuclear cells and induce M2-type macrophage polarization. Journal of Biological Chemistry, 284, 34342\u201334354.","journal-title":"Journal of Biological Chemistry"},{"key":"9484_CR106","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-065X.2012.01151.x","volume":"249","author":"AR Johnson","year":"2012","unstructured":"Johnson, A. R., Milner, J. J., & Makowski, L. (2012). The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunological Reviews, 249, 218\u2013238.","journal-title":"Immunological Reviews"},{"key":"9484_CR107","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cmet.2011.10.011","volume":"15","author":"R Stienstra","year":"2012","unstructured":"Stienstra, R., Tack, C. J. K. T., Joosten, L. A., & Netea, M. G. (2012). The inflammasome puts obesity in the danger zone. Cell Metabolism, 15, 10\u201318.","journal-title":"Cell Metabolism"},{"key":"9484_CR108","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof, A., & Despres, J. P. (2013). Pathophysiology of human visceral obesity: an update. Physiological Reviews, 93, 359\u2013404.","journal-title":"Physiological Reviews"},{"key":"9484_CR109","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla, S. (2001). Minireview: the OPG\/RANKL\/RANK system. Endocrinology, 142, 5050\u20135055.","journal-title":"Endocrinology"},{"key":"9484_CR110","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/endo.136.7.7789332","volume":"136","author":"RB Kimble","year":"1995","unstructured":"Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995). Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology, 136, 3054\u20133061.","journal-title":"Endocrinology"},{"key":"9484_CR111","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.24781","volume":"60","author":"R Axmann","year":"2009","unstructured":"Axmann, R. (2009). Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis and Rheumatism, 60, 2747\u20132756. doi: 10.1002\/art.24781 .","journal-title":"Arthritis and Rheumatism"},{"key":"9484_CR112","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1359\/jbmr.070409","volume":"22","author":"J Cauley","year":"2007","unstructured":"Cauley, J., Danielson, M., Boudreau, R., Forrest, K., Zmuda, J., Pahor, M., Tylavsky, F., Cummings, S., Harris, T., Newman, A., & Health ABC Study. (2007). Inflammatory markers and incident fracture risk in older Men and women: the health aging and body composition study. Journal of Bone and Mineral Research, 22, 1088\u20131095.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9484_CR113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI27280","volume":"116","author":"JG Neels","year":"2006","unstructured":"Neels, J. G., & Olefsky, J. M. (2006). Inflamed fat: what starts the fire? Journal of Clinical Investigation, 116, 33\u201335.","journal-title":"Journal of Clinical Investigation"},{"key":"9484_CR114","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W., Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation, 112, 1796\u20131808.","journal-title":"Journal of Clinical Investigation"},{"key":"9484_CR115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10555-006-9027-x","volume":"25","author":"MJ Craig","year":"2006","unstructured":"Craig, M. J., & Loberg, R. D. (2006). CCL2 (monocyte chemoattractant protein-1) in cancer bone metastases. Cancer Metastasis Reviews, 25, 611\u2013619.","journal-title":"Cancer Metastasis Reviews"},{"key":"9484_CR116","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","volume":"116","author":"SP Weisberg","year":"2006","unstructured":"Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Ferrante, A. W., Jr. (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation, 116, 115\u2013124.","journal-title":"Journal of Clinical Investigation"},{"key":"9484_CR117","doi-asserted-by":"crossref","first-page":"26602","DOI":"10.1074\/jbc.M601284200","volume":"281","author":"N Kamei","year":"2006","unstructured":"Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., Yamauchi, T., Ueki, K., Oishi, Y., Nishimura, S., Manabe, I., Hashimoto, H., Ohnishi, Y., Ogata, H., Tokuyama, K., Tsunoda, M., Ide, T., Murakami, K., Nagai, R., & Kadowaki, T. (2006). Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. Journal of Biological Chemistry, 281, 26602\u201326614.","journal-title":"Journal of Biological Chemistry"},{"key":"9484_CR118","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","volume":"116","author":"H Kanda","year":"2006","unstructured":"Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa, S., Miyachi, H., Maeda, S., Egashira, K., & Kasuga, M. (2006). MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Journal of Clinical Investigation, 116, 1494\u20131505.","journal-title":"Journal of Clinical Investigation"},{"key":"9484_CR119","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2008.08.120","volume":"44","author":"B Hopwood","year":"2009","unstructured":"Hopwood, B., Tsykin, A., Findlay, D. M., & Fazzalari, N. L. (2009). Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone, 44, 87\u2013101.","journal-title":"Bone"},{"key":"9484_CR120","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1074\/jbc.M412713200","volume":"280","author":"MS Kim","year":"2005","unstructured":"Kim, M. S., Day, C. J., & Morrison, N. A. (2005). MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. Journal of Biological Chemistry, 280, 16163\u201316169.","journal-title":"Journal of Biological Chemistry"},{"key":"9484_CR121","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.2741\/Graves","volume":"4","author":"DT Graves","year":"1999","unstructured":"Graves, D. T., Jiang, Y., & Valente, A. J. (1999). The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts. Frontiers in Bioscience, 4, D571\u2013580.","journal-title":"Frontiers in Bioscience"},{"key":"9484_CR122","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S8756-3282(97)00154-3","volume":"21","author":"LJ Posner","year":"1997","unstructured":"Posner, L. J., Miligkos, T., Gilles, J. A., Carnes, D. L., Taddeo, D. R., & Graves, D. T. (1997). Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. Bone, 21, 321\u2013327.","journal-title":"Bone"},{"key":"9484_CR123","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/jcp.22879","volume":"227","author":"OJ Sul","year":"2012","unstructured":"Sul, O. J., Ke, K., Kim, W. K., Kim, S. H., Lee, S. C., Kim, H. J., Kim, S. Y., Suh, J. H., & Choi, H. S. (2012). Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation. Journal of Cellular Physiology, 227, 1619\u20131627.","journal-title":"Journal of Cellular Physiology"},{"key":"9484_CR124","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","volume":"21","author":"KA Blackwell","year":"2010","unstructured":"Blackwell, K. A., Raisz, L. G., & Pilbeam, C. C. (2010). Prostaglandins in bone: bad cop, good cop? Trends in Endocrinology and Metabolism, 21, 294\u2013301.","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"9484_CR125","first-page":"181","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang, D., & Dubois, R. N. (2010). Eicosanoids and cancer. Nature Reviews., 10, 181\u2013193.","journal-title":"Nature Reviews."},{"key":"9484_CR126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1359\/jbmr.081002","volume":"24","author":"AA Naik","year":"2009","unstructured":"Naik, A. A., Xie, C., Zuscik, M. J., Kingsley, P., Schwarz, E. M., Awad, H., Guldberg, R., Drissi, H., Puzas, J. E., Boyce, B., Zhang, X., & O\u2019Keefe, R. J. (2009). Reduced COX-2 expression in aged mice is associated with impaired fracture healing. Journal of Bone and Mineral Research, 24, 251\u2013264.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9484_CR127","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1359\/jbmr.2002.17.6.963","volume":"17","author":"AM Simon","year":"2002","unstructured":"Simon, A. M., Manigrasso, M. B., & O\u2019Connor, J. P. (2002). Cyclo-oxygenase 2 function is essential for bone fracture healing. Journal of Bone and Mineral Research, 17, 963\u2013976.","journal-title":"Journal of Bone and Mineral Research"},{"key":"9484_CR128","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bone.2007.12.228","volume":"42","author":"XY Tian","year":"2008","unstructured":"Tian, X. Y., Zhang, Q., Zhao, R., Setterberg, R. B., Zeng, Q. Q., Iturria, S. J., Ma, Y. F., & Jee, W. S. (2008). Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats. Bone, 42, 914\u2013920.","journal-title":"Bone"},{"key":"9484_CR129","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/carcin\/bgp227","volume":"30","author":"YC Chen","year":"2009","unstructured":"Chen, Y. C., Sosnoski, D. M., Gandhi, U. H., Novinger, L. J., Prabhu, K. S., & Mastro, A. M. (2009). Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer. Carcinogenesis, 30, 1941\u20131948.","journal-title":"Carcinogenesis"},{"key":"9484_CR130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2362.2009.02239.x","volume":"40","author":"PS Hsieh","year":"2010","unstructured":"Hsieh, P. S., Lu, K. C., Chiang, C. F., & Chen, C. H. (2010). Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats. European Journal of Clinical Investigation, 40, 164\u2013171.","journal-title":"European Journal of Clinical Investigation"},{"key":"9484_CR131","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI118717","volume":"97","author":"GD Anderson","year":"1996","unstructured":"Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., & Gregory, S. A. (1996). Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. Journal of Clinical Investigation, 97, 2672\u20132679.","journal-title":"Journal of Clinical Investigation"},{"key":"9484_CR132","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1158\/0008-5472.CAN-06-4174","volume":"67","author":"P Sinha","year":"2007","unstructured":"Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand-Rosenberg, S. (2007). Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Research, 67, 4507\u20134513.","journal-title":"Cancer Research"},{"key":"9484_CR133","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/1078-0432.CCR-05-1052","volume":"12","author":"M Muta","year":"2006","unstructured":"Muta, M., Matsumoto, G., Nakashima, E., & Toi, M. (2006). Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation. Clinical Cancer Research, 12, 264\u2013272.","journal-title":"Clinical Cancer Research"},{"key":"9484_CR134","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","volume":"71","author":"M Fujita","year":"2011","unstructured":"Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R. L., Komohara, Y., Decker, S. A., Ohlfest, J. R., & Okada, H. (2011). COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Research, 71, 2664\u20132674.","journal-title":"Cancer Research"},{"key":"9484_CR135","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1093\/emboj\/cdf478","volume":"21","author":"AG Eliopoulos","year":"2002","unstructured":"Eliopoulos, A. G., Dumitru, C. D., Wang, C. C., Cho, J., & Tsichlis, P. N. (2002). Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO Journal, 21, 4831\u20134840.","journal-title":"EMBO Journal"},{"key":"9484_CR136","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","volume":"115","author":"S Nakao","year":"2005","unstructured":"Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Ueda, S., Kimura, Y. N., Hamano, S., Sonoda, K. H., Saijo, Y., Nukiwa, T., Strieter, R. M., Ishibashi, T., Kuwano, M., & Ono, M. (2005). Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. Journal of Clinical Investigation, 115, 2979\u20132991.","journal-title":"Journal of Clinical Investigation"},{"key":"9484_CR137","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/jpet.108.137992","volume":"326","author":"T Tajima","year":"2008","unstructured":"Tajima, T., Murata, T., Aritake, K., Urade, Y., Hirai, H., Nakamura, M., Ozaki, H., & Hori, M. (2008). Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). The Journal of Pharmacology and Experimental Therapeutics, 326, 493\u2013501.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"9484_CR138","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.2004.059824","volume":"55","author":"S Tanaka","year":"2006","unstructured":"Tanaka, S., Tatsuguchi, A., Futagami, S., Gudis, K., Wada, K., Seo, T., Mitsui, K., Yonezawa, M., Nagata, K., Fujimori, S., Tsukui, T., Kishida, T., & Sakamoto, C. (2006). Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut, 55, 54\u201361.","journal-title":"Gut"},{"key":"9484_CR139","first-page":"E827","volume":"280","author":"G Fruhbeck","year":"2001","unstructured":"Fruhbeck, G., Gomez-Ambrosi, J., Muruzabal, F. J., & Burrell, M. A. (2001). The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology., 280, E827\u2013847.","journal-title":"American Journal of Physiology."},{"key":"9484_CR140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1442-2042.2010.02472.x","volume":"17","author":"A Kaneko","year":"2010","unstructured":"Kaneko, A., Satoh, Y., Tokuda, Y., Fujiyama, C., Udo, K., & Uozumi, J. (2010). Effects of adipocytes on the proliferation and differentiation of prostate cancer cells in a 3-D culture model. International Journal of Urology, 17, 369\u2013376.","journal-title":"International Journal of Urology"},{"key":"9484_CR141","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"K Nieman","year":"2011","unstructured":"Nieman, K., Kenny, H., Penicka, C., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M., Romero, I., Carey, M., Mills, G., Hotamisligil, G., Yamada, S., Peter, M., Gwin, K., & Lengyel, E. (2011). Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature Medicine., 17, 1498\u20131503.","journal-title":"Nature Medicine."},{"key":"9484_CR142","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-410X.2003.04218.x","volume":"91","author":"Y Tokuda","year":"2003","unstructured":"Tokuda, Y., Satoh, Y., Fujiyama, C., Toda, S., Sugihara, H., & Masaki, Z. (2003). Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction. BJU International, 91, 716\u2013720.","journal-title":"BJU International"},{"key":"9484_CR143","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y., Meulle, A., Salles, B., Le Gonidec, S., Garrido, I., Escourrou, G., Valet, P., & Muller, C. (2011). Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Research, 71, 2455\u20132465.","journal-title":"Cancer Research"},{"key":"9484_CR144","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","volume":"1831","author":"KM Nieman","year":"2013","unstructured":"Nieman, K. M., Romero, I. L., Van Houten, B., & Lengyel, E. (2013). Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochimica et Biophysica Acta, 1831, 1533\u201341.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9484_CR145","first-page":"886","volume":"11","author":"MJ Khandekar","year":"2011","unstructured":"Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011). Molecular mechanisms of cancer development in obesity. Nature Reviews., 11, 886\u2013895.","journal-title":"Nature Reviews."},{"key":"9484_CR146","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.bbalip.2013.03.010","volume":"1831","author":"G Zadra","year":"2013","unstructured":"Zadra, G., Photopoulos, C., & Loda, M. (2013). The fat side of prostate cancer. Biochimica et Biophysica Acta, 1831, 1518\u20131532.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9484_CR147","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbalip.2013.04.011","volume":"1831","author":"A Llorente","year":"2013","unstructured":"Llorente, A., Skotland, T., Sylv\u00e4nne, T., Kauhanen, D., Rog, T., Or\u0142owski, A., Vattulainen, I., Ekroos, K., & Sandvig, K. (2013). Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochimica et Biophysica Acta, 1831, 1302\u20139.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9484_CR148","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1038\/sj.onc.1208622","volume":"24","author":"M Buzzai","year":"2005","unstructured":"Buzzai, M., Bauer, D. E., Jones, R. G., Deberardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005). The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene, 24, 4165\u20134173.","journal-title":"Oncogene"},{"key":"9484_CR149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2012.03.003","volume":"98","author":"J Suburu","year":"2012","unstructured":"Suburu, J., & Chen, Y. Q. (2012). Lipids and prostate cancer. Prostaglandins & Other Lipid Mediators, 98, 1\u201310.","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"9484_CR150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.pcan.4500879","volume":"9","author":"Y Liu","year":"2006","unstructured":"Liu, Y. (2006). Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer and Prostatic Diseases., 9, 230\u2013234.","journal-title":"Prostate Cancer and Prostatic Diseases."},{"key":"9484_CR151","doi-asserted-by":"crossref","unstructured":"Herroon, M., Rajagurubandara, E., Hardaway, A., Powell, K., Turchick, A., Feldmann, D., & Podgorski, I. (2013). Bone marrow adipocytes promote tumor growth and survival in bone via FABP4-dependent mechanisms. Oncotarget, 4, 2108\u20132123.","DOI":"10.18632\/oncotarget.1482"},{"key":"9484_CR152","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2741\/3810","volume":"16","author":"G Paz-Filho","year":"2011","unstructured":"Paz-Filho, G., Lim, E. L., Wong, M. L., & Licinio, J. (2011). Associations between adipokines and obesity-related cancer. Frontiers in Bioscience, 16, 1634\u20131650.","journal-title":"Frontiers in Bioscience"},{"key":"9484_CR153","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxm006","volume":"29","author":"SJ Freedland","year":"2007","unstructured":"Freedland, S. J., & Platz, E. A. (2007). Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiologic Reviews., 29, 88\u201397.","journal-title":"Epidemiologic Reviews."},{"key":"9484_CR154","first-page":"280386","volume":"2012","author":"MR Hoda","year":"2012","unstructured":"Hoda, M. R., Theil, G., Mohammed, N., Fischer, K., & Fornara, P. (2012). The adipocyte-derived hormone leptin has proliferative actions on androgen-resistant prostate cancer cells linking obesity to advanced stages of prostate cancer. Journal of Oncology., 2012, 280386.","journal-title":"Journal of Oncology."},{"key":"9484_CR155","doi-asserted-by":"crossref","first-page":"42660","DOI":"10.1074\/jbc.M304984200","volume":"278","author":"M Onuma","year":"2003","unstructured":"Onuma, M., Bub, J. D., Rummel, T. L., & Iwamoto, Y. (2003). Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. Journal of Biological Chemistry, 278, 42660\u201342667.","journal-title":"Journal of Biological Chemistry"},{"key":"9484_CR156","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","volume":"27","author":"K Bussard","year":"2008","unstructured":"Bussard, K., Gay, C., & Mastro, A. (2008). The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Reviews, 27, 41\u201355.","journal-title":"Cancer Metastasis Reviews"},{"key":"9484_CR157","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/cancers3010478","volume":"3","author":"MN Thobe","year":"2011","unstructured":"Thobe, M. N., Clark, R. J., Bainer, R. O., Prasad, S. M., & Rinker-Schaeffer, C. W. (2011). From prostate to bone: key players in prostate cancer bone metastasis. Cancers (Basel)., 3, 478\u2013493.","journal-title":"Cancers (Basel)."},{"key":"9484_CR158","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1054\/plef.2002.0430","volume":"67","author":"JN Fain","year":"2002","unstructured":"Fain, J. N., Kanu, A., Bahouth, S. W., Cowan, G. S., Jr., Hiler, M. L., & Leffler, C. W. (2002). Comparison of PGE2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostaglandins, Leukotrienes, and Essential Fatty Acids., 67, 467\u2013473.","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids."},{"key":"9484_CR159","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0022-2275(20)32003-4","volume":"41","author":"JN Fain","year":"2000","unstructured":"Fain, J. N., Leffler, C. W., & Bahouth, S. W. (2000). Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture. Journal of Lipid Research., 41, 1689\u20131694.","journal-title":"Journal of Lipid Research."},{"key":"9484_CR160","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.urology.2004.12.053","volume":"65","author":"S Goktas","year":"2005","unstructured":"Goktas, S., Yilmaz, M. I., Caglar, K., Sonmez, A., Kilic, S., & Bedir, S. (2005). Prostate cancer and adiponectin. Urology, 65, 1168\u20131172.","journal-title":"Urology"},{"key":"9484_CR161","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","volume":"94","author":"I Kelesidis","year":"2006","unstructured":"Kelesidis, I., Kelesidis, T., & Mantzoros, C. S. (2006). Adiponectin and cancer: a systematic review. British Journal of Cancer., 94, 1221\u20131225.","journal-title":"British Journal of Cancer."},{"key":"9484_CR162","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bbrc.2005.12.103","volume":"340","author":"JD Bub","year":"2006","unstructured":"Bub, J. D., Miyazaki, T., & Iwamoto, Y. (2006). Adiponectin as a growth inhibitor in prostate cancer cells. Biochemical and Biophysical Research Communications, 340, 1158\u20131166.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9484_CR163","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbrc.2006.07.139","volume":"348","author":"T Mistry","year":"2006","unstructured":"Mistry, T., Digby, J. E., Chen, J., Desai, K. M., & Randeva, H. S. (2006). The regulation of adiponectin receptors in human prostate cancer cell lines. Biochemical and Biophysical Research Communications, 348, 832\u2013838.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9484_CR164","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eururo.2007.03.054","volume":"52","author":"T Mistry","year":"2007","unstructured":"Mistry, T., Digby, J. E., Desai, K. M., & Randeva, H. S. (2007). Obesity and prostate cancer: a role for adipokines. European Urology., 52, 46\u201353.","journal-title":"European Urology."},{"key":"9484_CR165","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1464-410X.2008.07512.x","volume":"101","author":"T Mistry","year":"2008","unstructured":"Mistry, T., Digby, J. E., Desai, K. M., & Randeva, H. S. (2008). Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression. BJU International, 101, 1317\u20131322.","journal-title":"BJU International"},{"key":"9484_CR166","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1172\/JCI0214506","volume":"109","author":"T Yokota","year":"2002","unstructured":"Yokota, T., Meka, C. S., Medina, K. L., Igarashi, H., Comp, P. C., Takahashi, M., Nishida, M., Oritani, K., Miyagawa, J., Funahashi, T., Tomiyama, Y., Matsuzawa, Y., & Kincade, P. W. (2002). Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. Journal of Clinical Investigation, 109, 1303\u20131310.","journal-title":"Journal of Clinical Investigation"},{"key":"9484_CR167","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.4049\/jimmunol.171.10.5091","volume":"171","author":"T Yokota","year":"2003","unstructured":"Yokota, T., Meka, C. S., Kouro, T., Medina, K. L., Igarashi, H., Takahashi, M., Oritani, K., Funahashi, T., Tomiyama, Y., Matsuzawa, Y., & Kincade, P. W. (2003). Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. The Journal of Immunology, 171, 5091\u20135099.","journal-title":"The Journal of Immunology"},{"key":"9484_CR168","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1470-2045(03)01220-8","volume":"4","author":"G Gasparini","year":"2003","unstructured":"Gasparini, G., Longo, R., Sarmiento, R., & Morabito, A. (2003). Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? The Lancet Oncology, 4, 605\u2013615.","journal-title":"The Lancet Oncology"},{"key":"9484_CR169","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski, P. (2012). Regulation of immune responses by prostaglandin E2. The Journal of Immunology, 188, 21\u201328.","journal-title":"The Journal of Immunology"},{"key":"9484_CR170","doi-asserted-by":"crossref","first-page":"e46342","DOI":"10.1371\/journal.pone.0046342","volume":"7","author":"J Karavitis","year":"2012","unstructured":"Karavitis, J., Hix, L., Shi, Y., Schultz, R., Khazaie, K., & Zhang, M. (2012). Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration. PLoS ONE, 7, e46342.","journal-title":"PLoS ONE"},{"key":"9484_CR171","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-008-0135-x","volume":"117","author":"A Lucci","year":"2009","unstructured":"Lucci, A., Krishnamurthy, S., Singh, B., Bedrosian, I., Meric-Bernstam, F., Reuben, J., Broglio, K., Mosalpuria, K., Lodhi, A., Vincent, L., & Cristofanilli, M. (2009). Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Research and Treatment, 117, 61\u201368.","journal-title":"Breast Cancer Research and Treatment"},{"key":"9484_CR172","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/1541-7786.MCR-10-0196","volume":"9","author":"A Safina","year":"2011","unstructured":"Safina, A., Sotomayor, P., Limoge, M., Morrison, C., & Bakin, A. (2011). TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells. Molecular Cancer Research, 9, 1042\u20131053.","journal-title":"Molecular Cancer Research"},{"key":"9484_CR173","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/sj.onc.1210154","volume":"26","author":"B Singh","year":"2007","unstructured":"Singh, B., Berry, J., Shoher, A., Ayers, G., Wei, C., & Lucci, A. (2007). COX-2 involvement in breast cancer metastasis to bone. Oncogene, 26, 3789\u20133796.","journal-title":"Oncogene"},{"key":"9484_CR174","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10585-007-9117-3","volume":"25","author":"Z Li","year":"2008","unstructured":"Li, Z., Schem, C., Shi, Y., Medina, D., & Zhang, M. (2008). Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis. Clinical and Experimental Metastasis, 25, 389\u2013400.","journal-title":"Clinical and Experimental Metastasis"},{"key":"9484_CR175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/emm.2007.51","volume":"39","author":"E Lee","year":"2007","unstructured":"Lee, E., Choi, E., Kim, S., Park, J., Kim, H., Ha, K., Kim, Y., Kim, S., Choe, M., Kim, J., & Han, J. (2007). Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells. Experimental and Molecular Medicine, 39, 469\u2013476.","journal-title":"Experimental and Molecular Medicine"},{"key":"9484_CR176","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.febslet.2007.01.005","volume":"581","author":"M Takita","year":"2007","unstructured":"Takita, M., Inada, M., Maruyama, T., & Miyaura, C. (2007). Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells. FEBS Letters, 581, 565\u2013571.","journal-title":"FEBS Letters"},{"key":"9484_CR177","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1479-5876-9-142","volume":"9","author":"M Valcarcel","year":"2011","unstructured":"Valcarcel, M., Mendoza, L., Hernandez, J. J., Carrascal, T., Salado, C., Crende, O., & Vidal-Vanaclocha, F. (2011). Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. Journal of Translational Medicine, 9, 142.","journal-title":"Journal of Translational Medicine"},{"key":"9484_CR178","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)67321-1","volume":"164","author":"XH Liu","year":"2000","unstructured":"Liu, X. H., Kirschenbaum, A., Yao, S., Lee, R., Holland, J. F., & Levine, A. C. (2000). Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. The Journal of Urology., 164, 820\u2013825.","journal-title":"The Journal of Urology."},{"key":"9484_CR179","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/en.2012-2074","volume":"154","author":"B Vo","year":"2013","unstructured":"Vo, B., Morton, D. S. K., Millena, A., Leath, C., & Khan, S. (2013). TGF-\u03b2 effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K\/AKT\/mTOR pathway. Endocrinology, 154, 1768\u20131779.","journal-title":"Endocrinology"},{"key":"9484_CR180","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/0008-5472.CAN-05-2012","volume":"66","author":"T Hiraga","year":"2006","unstructured":"Hiraga, T., Myoui, A., Choi, M. E., Yoshikawa, H., & Yoneda, T. (2006). Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Research, 66, 2067\u20132073.","journal-title":"Cancer Research"},{"key":"9484_CR181","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1158\/1535-7163.MCT-08-0153","volume":"7","author":"T Takahashi","year":"2008","unstructured":"Takahashi, T., Uehara, H., Bando, Y., & Izumi, K. (2008). Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth. Molecular Cancer Therapeutics, 7, 2807\u20132816.","journal-title":"Molecular Cancer Therapeutics"},{"key":"9484_CR182","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1158\/0008-5472.CAN-12-3970","volume":"73","author":"Q Liu","year":"2013","unstructured":"Liu, Q., Russell, M. R., Shahriari, K., Jernigan, D. L., Lioni, M. I., Garcia, F. U., & Fatatis, A. (2013). Interleukin-1beta promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features. Cancer Research, 73, 3297\u20133305.","journal-title":"Cancer Research"},{"key":"9484_CR183","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00418-008-0527-3","volume":"130","author":"MA Bitoux Le","year":"2008","unstructured":"Le Bitoux, M. A., & Stamenkovic, I. (2008). Tumor-host interactions: the role of inflammation. Histochemistry and Cell Biology., 130, 1079\u20131090.","journal-title":"Histochemistry and Cell Biology."},{"key":"9484_CR184","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/2159-8290.CD-12-0101","volume":"2","author":"HJ Li","year":"2012","unstructured":"Li, H. J., Reinhardt, F., Herschman, H. R., & Weinberg, R. A. (2012). Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discovery., 2, 840\u2013855.","journal-title":"Cancer Discovery."},{"key":"9484_CR185","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1593\/neo.06280","volume":"8","author":"R Loberg","year":"2006","unstructured":"Loberg, R., Day, L., Harwood, J., Ying, C., St John, L., Giles, R., Neeley, C., & Pienta, K. (2006). CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia, 8, 578\u2013586.","journal-title":"Neoplasia"},{"key":"9484_CR186","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1593\/neo.07307","volume":"9","author":"RD Loberg","year":"2007","unstructured":"Loberg, R. D., Ying, C., Craig, M., Yan, L., Snyder, L. A., & Pienta, K. J. (2007). CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia, 9, 556\u2013562.","journal-title":"Neoplasia"},{"key":"9484_CR187","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/pros.20464","volume":"66","author":"Y Lu","year":"2006","unstructured":"Lu, Y., Cai, Z., Galson, D. L., Xiao, G., Liu, Y., George, D. E., Melhem, M. F., Yao, Z., & Zhang, J. (2006). Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate, 66, 1311\u20131318.","journal-title":"Prostate"},{"key":"9484_CR188","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/onc.2012.166","volume":"32","author":"M Herroon","year":"2013","unstructured":"Herroon, M., Rajagurubandara, E. D. R., Chalasani, A., Hardaway, A., & Podgorski, I. (2013). Macrophage cathepsin K promotes prostate tumor progression in bone. Oncogene, 32, 1580\u20131593.","journal-title":"Oncogene"},{"key":"9484_CR189","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian, B. Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011). CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature, 475, 222\u20135.","journal-title":"Nature"},{"key":"9484_CR190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2009.11.009","volume":"21","author":"J Zhang","year":"2010","unstructured":"Zhang, J., Patel, L., & Pienta, K. (2010). CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine and Growth Factor Reviews, 21, 41\u201348.","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"9484_CR191","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1158\/0008-5472.CAN-06-1210","volume":"67","author":"Y Lu","year":"2007","unstructured":"Lu, Y., Cai, Z., Xiao, G., Keller, E., Mizokami, A., Yao, Z., Roodman, G., & Zhang, J. (2007). Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Research, 67, 3646\u20133653.","journal-title":"Cancer Research"},{"key":"9484_CR192","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/0008-5472.CAN-08-2164","volume":"69","author":"X Li","year":"2009","unstructured":"Li, X., Loberg, R., Liao, J., Ying, C., Snyder, L., Pienta, K., & McCauley, L. (2009). A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Research, 69, 1685\u20131692.","journal-title":"Cancer Research"},{"key":"9484_CR193","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1593\/neo.09988","volume":"11","author":"K Mizutani","year":"2009","unstructured":"Mizutani, K., Sud, S., McGregor, N., Martinovski, G., Rice, B., Craig, M., Varsos, Z., Roca, H., & Pienta, K. (2009). The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia, 11, 1235\u20131242.","journal-title":"Neoplasia"},{"key":"9484_CR194","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10585-008-9226-7","volume":"26","author":"Y Lu","year":"2009","unstructured":"Lu, Y., Chen, Q., Corey, E., Xie, W., Fan, J., Mizokami, A., & Zhang, J. (2009). Activation of MCP-1\/CCR2 axis promotes prostate cancer growth in bone. Clinical and Experimental Metastasis, 26, 161\u2013169.","journal-title":"Clinical and Experimental Metastasis"},{"key":"9484_CR195","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.yexcr.2011.07.024","volume":"317","author":"A Nalla","year":"2011","unstructured":"Nalla, A., Estes, N., Patel, J., & Rao, J. (2011). N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K\/Akt signaling in prostate cancer cells. Experimental Cell Research, 317, 2512\u20132521.","journal-title":"Experimental Cell Research"},{"key":"9484_CR196","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/oby.2008.674","volume":"17","author":"PS Hsieh","year":"2009","unstructured":"Hsieh, P. S., Jin, J. S., Chiang, C. F., Chan, P. C., Chen, C. H., & Shih, K. C. (2009). COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity, 17, 1150\u20131157 (Silver Spring, MD).","journal-title":"Obesity"},{"key":"9484_CR197","doi-asserted-by":"crossref","first-page":"12517","DOI":"10.1074\/jbc.271.21.12517","volume":"271","author":"MJ Bossard","year":"1996","unstructured":"Bossard, M. J., Tomaszek, T. A., Thompson, S. K., Amegadzie, B. Y., Hanning, C. R., Jones, C., Kurdyla, J. T., McNulty, D. E., Drake, F. H., Gowen, M., & Levy, M. A. (1996). Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. Journal of Biological Chemistry, 271, 12517\u201312524.","journal-title":"Journal of Biological Chemistry"},{"key":"9484_CR198","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1158\/0008-5472.CAN-09-1451","volume":"69","author":"BK Popivanova","year":"2009","unstructured":"Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., & Mukaida, N. (2009). Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Research, 69, 7884\u20137892.","journal-title":"Cancer Research"},{"key":"9484_CR199","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/pros.22531","volume":"72","author":"M Huang","year":"2012","unstructured":"Huang, M., Narita, S., Numakura, K., Tsuruta, H., Saito, M., Inoue, T., Horikawa, Y., Tsuchiya, N., & Habuchi, T. (2012). A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1\/CCR2 signaling. Prostate, 72, 1779\u20131788.","journal-title":"Prostate"},{"key":"9484_CR200","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","volume":"32","author":"K Pienta","year":"2013","unstructured":"Pienta, K., Machiels, J., Schrijvers, D., Alekseev, B., Shkolnik, M., Crabb, S., Li, S., Seetharam, S., Puchalski, T., Takimoto, C., Elsayed, Y., Dawkins, F., & de Bono, J. (2013). Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Investigational New Drugs, 32, 760\u2013768.","journal-title":"Investigational New Drugs"},{"key":"9484_CR201","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/pros.21297","volume":"71","author":"P Abedinpour","year":"2011","unstructured":"Abedinpour, P., Baron, V. J. W., & Borgstr\u00f6m, P. (2011). Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo. Prostate, 71, 813\u2013823.","journal-title":"Prostate"},{"key":"9484_CR202","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1200\/JCO.2009.21.9410","volume":"27","author":"E Antonarakis","year":"2009","unstructured":"Antonarakis, E., Heath, E., Walczak, J., Nelson, W., Fedor, H., De Marzo, A., Zahurak, M., Piantadosi, S., Dannenberg, A., Gurganus, R., Baker, S., Parnes, H., DeWeese, T., Partin, A., & Carducci, M. (2009). Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers. Journal of Clinical Oncology, 27, 4986\u20134993.","journal-title":"Journal of Clinical Oncology"},{"key":"9484_CR203","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1464-410X.2008.08034.x","volume":"103","author":"N James","year":"2009","unstructured":"James, N., Sydes, M., Clarke, N., Mason, M., Dearnaley, D., Anderson, J., Popert, R., Sanders, K., Morgan, R., Stansfeld, J., Dwyer, J., Masters, J., & Parmar, M. (2009). Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. BJU., 103, 464\u2013469.","journal-title":"BJU."},{"key":"9484_CR204","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2011.01.012","volume":"332","author":"V Jendrossek","year":"2013","unstructured":"Jendrossek, V. (2013). Targeting apoptosis pathways by Celecoxib in cancer. Cancer Letters, 332, 313\u2013324.","journal-title":"Cancer Letters"},{"key":"9484_CR205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3816\/CGC.2005.n.034","volume":"4","author":"RS Pruthi","year":"2005","unstructured":"Pruthi, R. S., & Wallen, E. M. (2005). Cyclooxygenase-2: a therapeutic target for prostate cancer. Clinical Genitourinary Cancer, 4, 203\u2013211.","journal-title":"Clinical Genitourinary Cancer"},{"key":"9484_CR206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1179\/joc.2007.19.1.21","volume":"19","author":"P Sooriakumaran","year":"2007","unstructured":"Sooriakumaran, P., Langley, S. E., Laing, R. W., & Coley, H. M. (2007). COX-2 inhibition: a possible role in the management of prostate cancer? Journal of Chemotherapy., 19, 21\u201332.","journal-title":"Journal of Chemotherapy."},{"key":"9484_CR207","unstructured":"www.Clinicaltrials.gov . (2011) Effects of ASA on prostate tissue NCT00234299"},{"key":"9484_CR208","unstructured":"www.Clinicaltrials.gov . (2013) Dexamethasone, aspirin, and diethylstilbestrol in treating patients with locally advanced or metastatic prostate cancer NCT00316927"},{"key":"9484_CR209","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.critrevonc.2006.07.001","volume":"61","author":"DJ Groot de","year":"2007","unstructured":"de Groot, D. J., de Vries, E. G., Groen, H. J., & de Jong, S. (2007). Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Critical Reviews in Oncology\/Hematology., 61, 52\u201369.","journal-title":"Critical Reviews in Oncology\/Hematology."},{"key":"9484_CR210","first-page":"130","volume":"6","author":"CM Ulrich","year":"2006","unstructured":"Ulrich, C. M., Bigler, J., & Potter, J. D. (2006). Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nature Reviews., 6, 130\u2013140.","journal-title":"Nature Reviews."},{"key":"9484_CR211","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1080\/10428190802108854","volume":"49","author":"P Robak","year":"2008","unstructured":"Robak, P., Smolewski, P., & Robak, T. (2008). The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies. Leukemia & Lymphoma., 49, 1452\u20131462.","journal-title":"Leukemia & Lymphoma."},{"key":"9484_CR212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/ERC-12-0344","volume":"20","author":"E Kashiwagi","year":"2013","unstructured":"Kashiwagi, E., Shiota, M., Yokomizo, A., Itsumi, M., Inokuchi, J., Uchiumi, T., & Naito, S. (2013). Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells. Endocrine-Related Cancer, 20, 431\u2013441.","journal-title":"Endocrine-Related Cancer"},{"key":"9484_CR213","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrurol.2013.137","volume":"10","author":"M Bishr","year":"2013","unstructured":"Bishr, M., & Saad, F. (2013). Overview of the latest treatments for castration-resistant prostate cancer. Nature reviews Urology, 10, 522\u2013528.","journal-title":"Nature reviews Urology"},{"key":"9484_CR214","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/BOR.0b013e3283025e9c","volume":"20","author":"G Duque","year":"2008","unstructured":"Duque, G. (2008). Bone and fat connection in aging bone. Current Opinion in Rheumatology., 20, 429\u2013434.","journal-title":"Current Opinion in Rheumatology."},{"key":"9484_CR215","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.coph.2004.03.002","volume":"4","author":"ME Nuttall","year":"2004","unstructured":"Nuttall, M. E., & Gimble, J. M. (2004). Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Current Opinion in Pharmacology., 4, 290\u2013294.","journal-title":"Current Opinion in Pharmacology."},{"key":"9484_CR216","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1158\/0008-5472.CAN-07-1286","volume":"67","author":"R Loberg","year":"2007","unstructured":"Loberg, R., Ying, C., Craig, M., Day, L., Sargent, E., Neeley, C., Wojno, K., Snyder, L., Yan, L., & Pienta, K. (2007). Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Research, 67, 9417\u20139424.","journal-title":"Cancer Research"},{"key":"9484_CR217","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","volume":"71","author":"S Sandhu","year":"2013","unstructured":"Sandhu, S., Papadopoulos, K., Fong, P., Patnaik, A., Messiou, C., Olmos, D., Wang, G., Tromp, B., Puchalski, T., Balkwill, F., Berns, B., Seetharam, S., de Bono, J., & Tolcher, A. (2013). A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemotherapy and Pharmacology, 71, 1041\u20131050.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"9484_CR218","unstructured":"www.Clinicaltrials.gov . (2013) An open-label, multicenter, phase 2 study of single-agent CNTO 888 (an anti-CCL2 monoclonal antibody) for the treatment of subjects with metastatic castrate-resistant prostate cancer. NCT00992186"},{"key":"9484_CR219","unstructured":"www.Clinicaltrials.gov . (2012) S0916, MLN1202 in treating patients with bone metastases. NCT01015560"},{"key":"9484_CR220","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1158\/1078-0432.CCR-07-0242","volume":"13","author":"X Zheng","year":"2007","unstructured":"Zheng, X., Cui, X., Avila, G., Huang, M., Liu, Y., Patel, J., Kong, A., Paulino, R., Shih, W., Lin, Y., Rabson, A., Reddy, B., & Conney, A. (2007). Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice. Clinical Cancer Research, 13, 5480\u20135487.","journal-title":"Clinical Cancer Research"},{"key":"9484_CR221","unstructured":"www.Clinicaltrials.gov . (2013) COX-2 inhibitor reduces serum PSA levels might predict a lower risk of prostatic cancer in men with LUTS\/BPH with an elevated PSA level. NCT01678313"},{"key":"9484_CR222","unstructured":"www.Clinicaltrials.gov . (2013) STAMPEDE: systemic therapy in advancing or metastatic prostate cancer: evaluation of drug efficacy: a multi-stage multi-arm randomised controlled trial. NCT00268476"},{"key":"9484_CR223","unstructured":"www.Clinicaltrials.gov . (2013) A trial of COX-2 inhibitors in PSA recurrence after definitive radiation or radical prostatectomy for prostate cancer. NCT00073970"},{"key":"9484_CR224","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/cncr.23806","volume":"113","author":"E Singer","year":"2008","unstructured":"Singer, E., Palapattu, G., & van Wijngaarden, E. (2008). Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey. Cancer, 113, 2053\u20132057.","journal-title":"Cancer"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-013-9484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-013-9484-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-013-9484-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:55:31Z","timestamp":1647888931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-013-9484-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":224,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9484"],"URL":"https:\/\/doi.org\/10.1007\/s10555-013-9484-y","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}